当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析

国邦医药

(605507)

  

流通市值:58.68亿  总市值:108.69亿
流通股本:3.02亿   总股本:5.59亿

国邦医药(605507)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润7.81亿元,每股收益1.40元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益805205.72万元,未分配利润366830.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产1078043.62万元,负债272837.89万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入5,890,839,205.644,418,147,150.192,892,356,514.661,338,703,044.52
营业总成本5,007,120,720.063,724,615,529.842,397,206,396.41,100,097,238.84
营业利润895,067,447.8673,947,665.53472,459,269.3236,105,375.84
利润总额887,969,784.1664,632,411.33464,089,147.75234,023,535.39
净利润780,577,499.03578,638,198.06404,368,991.62198,578,686.05
其他综合收益----
综合收益总额780,577,499.03578,638,198.06404,368,991.62198,578,686.05
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计5,874,299,808.135,659,848,826.365,113,132,959.295,420,999,260.3
非流动资产合计4,906,136,359.454,973,538,184.634,973,828,326.24,979,763,350.44
资产总计10,780,436,167.5810,633,387,010.9910,086,961,285.4910,400,762,610.74
流动负债合计2,557,787,418.172,562,823,970.692,260,407,146.992,175,003,655.1
非流动负债合计170,591,500.78224,703,960.42250,597,762.11617,047,396.24
负债合计2,728,378,918.952,787,527,931.112,511,004,909.12,792,051,051.34
归属于母公司股东权益合计8,047,340,282.197,840,370,923.667,570,450,395.247,603,179,108.72
股东权益合计8,052,057,248.637,845,859,079.887,575,956,376.397,608,711,559.4
负债和股东权益合计10,780,436,167.5810,633,387,010.9910,086,961,285.4910,400,762,610.74
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计4,574,322,268.543,400,423,392.912,193,820,857.521,058,961,855.16
经营活动现金流出小计3,867,911,412.693,367,545,491.32,443,804,677.781,138,076,451.23
经营活动产生的现金流量净额706,410,855.8532,877,901.61-249,983,820.26-79,114,596.07
投资活动现金流入小计5,323,802,456.311,332,474,826.26345,993,149.8193,197,809.94
投资活动现金流出小计5,837,648,418.781,733,737,826.04561,393,072.57188,814,603.79
投资活动产生的现金流量净额-513,845,962.47-401,262,999.78-215,399,922.774,383,206.15
筹资活动现金流入小计690,903,824.79770,140,750.55488,580,060203,530,000
筹资活动现金流出小计1,077,397,819.21921,177,462.39656,992,575.39129,417,478.25
筹资活动产生的现金流量净额-386,493,994.42-151,036,711.84-168,412,515.3974,112,521.75
汇率变动对现金及现金等价物的影响27,075,876.7114,130,878.7316,456,907.776,141,957.14
现金及现金等价物净增加额-166,853,224.33-505,290,931.28-617,339,350.655,523,088.97
期末现金及现金等价物余额1,534,371,563.841,195,933,856.891,083,885,437.521,706,747,877.14
最新报告期:2025-04-06
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国信证券李瑞楠,鲁家瑞1.621.781.932025-04-06
西部证券李梦园1.691.992.302025-04-04
中信建投刘若飞,王云鹏,袁清慧,贺菊颖,赖俊勇1.672.022.402025-04-04
华西证券崔文亮,徐顺利1.712.062.402025-04-02
西南证券徐卿1.882.252.532025-04-01
TOP↑